<DOC>
	<DOCNO>NCT00120055</DOCNO>
	<brief_summary>The aim study investigate whether pharmacokinetics atorvastatin and/or metabolite alter patient confirm atorvastatin-induced myopathy compare healthy control .</brief_summary>
	<brief_title>Association Between Systemic Exposure Atorvastatin Metabolites Atorvastatin-induced Myotoxicity</brief_title>
	<detailed_description>A 24 hour pharmacokinetic investigation atorvastatin metabolite perform 15 patient history atorvastatin -induced myotoxicity . The possible link relevant mutation SLCO1B1 , CYP3A5 MDR1 also investigate</detailed_description>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>18 year previous history atorvastatinassociated myotoxicity current treatment drug herbal remedy know pharmacokinetic interaction potential atorvastatin previous CK level ten time upper limit normal range pregnancy persistent muscular complaint four week washout period statin treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>